{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:09:03Z","timestamp":1763017743209,"version":"3.37.3"},"reference-count":48,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2017,5,5]],"date-time":"2017-05-05T00:00:00Z","timestamp":1493942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>The role of allogenic stem cell transplantation (<jats:styled-content style=\"fixed-case\">ASCT<\/jats:styled-content>) is still debated in myelofibrosis (MF).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective analyzed was performed to compare the outcome of 71 patients with intermediate\u20102 or high\u2010risk Dynamic International Prognosis Scoring System+ (<jats:styled-content style=\"fixed-case\">DIPSS<\/jats:styled-content>+) primary (<jats:styled-content style=\"fixed-case\">PMF<\/jats:styled-content>) or secondary (<jats:styled-content style=\"fixed-case\">SMF<\/jats:styled-content>) myelofibrosis with an indication of <jats:styled-content style=\"fixed-case\">ASCT<\/jats:styled-content> as they ultimately underwent the procedure (n=34) or not (n=37).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Five\u2010year overall survival (<jats:styled-content style=\"fixed-case\">OS<\/jats:styled-content>) was not statistically different between both groups (allograft: 52% vs no allograft: 34%, <jats:italic>P<\/jats:italic>=.12). However, progression to myelodysplastic syndrome or acute myeloid leukemia at 5\u00a0years was significantly lower in transplanted patients (14% vs 50%, <jats:italic>P<\/jats:italic>=.01). In univariate analysis, 5\u2010year <jats:styled-content style=\"fixed-case\">OS<\/jats:styled-content> was significantly higher for transplanted vs non\u2010transplanted patients with unfavorable karyotype (75% vs 0%, <jats:italic>P<\/jats:italic>=.001), <jats:styled-content style=\"fixed-case\">SMF<\/jats:styled-content> (71% vs 20%, <jats:italic>P<\/jats:italic>=.001) or high <jats:styled-content style=\"fixed-case\">DIPSS<\/jats:styled-content>+ score (46% vs 15%, <jats:italic>P<\/jats:italic>=.03). There was also a trend for better 5\u2010year <jats:styled-content style=\"fixed-case\">OS<\/jats:styled-content> in allografted patients with high <jats:styled-content style=\"fixed-case\">JAK<\/jats:styled-content>2<jats:sub>V617F<\/jats:sub> burden (&gt;65%) (75% vs 8%, <jats:italic>P<\/jats:italic>=.07). Interestingly, the survival of patients who did not proceed to <jats:styled-content style=\"fixed-case\">ASCT<\/jats:styled-content> was dramatically increased by the use of ruxolitinib.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Not all intermediate\u20102\/high\u2010risk <jats:styled-content style=\"fixed-case\">DIPSS<\/jats:styled-content>+ <jats:styled-content style=\"fixed-case\">MF<\/jats:styled-content> patients benefit from <jats:styled-content style=\"fixed-case\">ASCT<\/jats:styled-content>, especially since the introduction of <jats:styled-content style=\"fixed-case\">JAK<\/jats:styled-content>2 inhibitors.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ejh.12891","type":"journal-article","created":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T20:07:33Z","timestamp":1491250053000},"page":"60-69","source":"Crossref","is-referenced-by-count":5,"title":["Is allogeneic stem cell transplantation for myelofibrosis still indicated at the time of molecular markers and <scp>JAK<\/scp> inhibitors era?"],"prefix":"10.1111","volume":"99","author":[{"given":"Elsa","family":"Lestang","sequence":"first","affiliation":[{"name":"Hematology Department CHU Hotel\u2010Dieu  Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Peterlin","sequence":"additional","affiliation":[{"name":"Hematology Department CHU Hotel\u2010Dieu  Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannick","family":"Le Bris","sequence":"additional","affiliation":[{"name":"Hematology\/Biology Department CHU Hotel\u2010Dieu  Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviane","family":"Dubruille","sequence":"additional","affiliation":[{"name":"Hematology Department CHU Hotel\u2010Dieu  Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Delaunay","sequence":"additional","affiliation":[{"name":"Hematology Department CHU Hotel\u2010Dieu  Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Godon","sequence":"additional","affiliation":[{"name":"Hematology\/Biology Department CHU Hotel\u2010Dieu  Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Theisen","sequence":"additional","affiliation":[{"name":"Hematology\/Biology Department CHU Hotel\u2010Dieu  Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Blin","sequence":"additional","affiliation":[{"name":"Hematology Department CHU Hotel\u2010Dieu  Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Mahe","sequence":"additional","affiliation":[{"name":"Hematology Department CHU Hotel\u2010Dieu  Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Gastinne","sequence":"additional","affiliation":[{"name":"Hematology Department CHU Hotel\u2010Dieu  Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Garnier","sequence":"additional","affiliation":[{"name":"Hematology Department CHU Hotel\u2010Dieu  Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrille","family":"Touzeau","sequence":"additional","affiliation":[{"name":"Hematology Department CHU Hotel\u2010Dieu  Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maud","family":"Voldoire","sequence":"additional","affiliation":[{"name":"Hematology Department CHU Hotel\u2010Dieu  Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie C.","family":"Bene","sequence":"additional","affiliation":[{"name":"Hematology\/Biology Department CHU Hotel\u2010Dieu  Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Le Gouill","sequence":"additional","affiliation":[{"name":"Hematology Department CHU Hotel\u2010Dieu  Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel","family":"Milpied","sequence":"additional","affiliation":[{"name":"Hematology Department CHU Hotel\u2010Dieu  Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"Mohty","sequence":"additional","affiliation":[{"name":"Hematology Department CHU Hotel\u2010Dieu  Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1780-8746","authenticated-orcid":false,"given":"Philippe","family":"Moreau","sequence":"additional","affiliation":[{"name":"Hematology Department CHU Hotel\u2010Dieu  Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Guillaume","sequence":"additional","affiliation":[{"name":"Hematology Department CHU Hotel\u2010Dieu  Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3142-5581","authenticated-orcid":false,"given":"Patrice","family":"Chevallier","sequence":"additional","affiliation":[{"name":"Hematology Department CHU Hotel\u2010Dieu  Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,5,5]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.31.8436"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12013"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2014.31"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.3.1013.1013"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-170449"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-09-245837"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.2446"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-608315"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature03546"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2009.149"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030270"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1311347"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-578435"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.3"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110557"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110556"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.119545"},{"volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","year":"2008","author":"Swerdlow SC","key":"e_1_2_8_19_1"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404914"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2011.110"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-2004"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-488098"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2005.09.004"},{"key":"e_1_2_8_25_1","first-page":"825","article-title":"1994 Consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka D","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.233"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2006.11.004"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-234880"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.10.025"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08417.x"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-372904"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.094284"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2013.10.018"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-572545"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-107748"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.8711"},{"key":"e_1_2_8_37_1","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1182\/blood.V124.21.406.406","article-title":"Integration of mutations and karyotype towards a genetics\u2010based prognostic scoring system (GPSS) for primary myelofibrosis","volume":"124","author":"Tefferi A","year":"2014","journal-title":"Blood"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.405.405"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.12828"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2009.10"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2011.91"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.02.019"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.06.011"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12455"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.10.005"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.212"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-12-260588"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.277"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.14"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fejh.12891","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ejh.12891","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T08:45:00Z","timestamp":1696322700000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ejh.12891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,5]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["10.1111\/ejh.12891"],"URL":"https:\/\/doi.org\/10.1111\/ejh.12891","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"type":"print","value":"0902-4441"},{"type":"electronic","value":"1600-0609"}],"subject":[],"published":{"date-parts":[[2017,5,5]]}}}